Custom gene editing for disease prevention
Pro Research Analysisby 
Searched over 200M research papers
Advances in Custom Gene Editing for Disease Prevention
Custom gene editing is rapidly transforming the landscape of disease prevention, offering new ways to target, correct, or eliminate genetic causes of disease before symptoms arise. The most prominent technologies, including CRISPR-Cas systems, base editors, and synthetic gene circuits, are at the forefront of this revolution.
CRISPR-Cas and Programmable Nucleases in Disease Prevention
CRISPR-Cas systems are widely recognized as the leading programmable nucleases for gene editing, with researchers expecting them to be the mainstream tool for the next decade. These technologies are anticipated to be especially effective in preventing and treating infectious diseases, cancer, and hereditary conditions, both monogenic and polygenic in nature. However, challenges such as off-target mutations, achieving sufficient editing efficiency, and targeting specific tissues remain significant hurdles. Regulatory and ethical concerns also play a major role in shaping the future of gene editing for disease prevention Rocha2020Dai2020Li2022.
Base Editing and RNA Editing for Cancer and Genetic Disorders
Base editing, including the use of Endogenous-ADAR base editors, allows for precise changes at the nucleotide level, offering a safer and more flexible approach, especially for correcting single nucleotide variants (SNVs) associated with cancer predisposition and other genetic diseases. Recent systematic evaluations show that a significant proportion of pathogenic germline and driver mutations in cancer can be targeted by these editors, with minimal off-target effects, highlighting their potential for both prevention and treatment of cancer and other inherited disorders .
Gene Editing for Cardiovascular Disease Prevention
Gene editing is also making strides in the prevention of cardiovascular diseases (CVDs). CRISPR-Cas9, for example, has been used to target genes like PCSK9, which play a key role in cholesterol regulation and atherosclerosis risk. Early clinical studies, such as those involving VERVE-101, demonstrate the feasibility and promise of these approaches. However, concerns about off-target effects, immune responses, and long-term safety must be addressed before widespread clinical adoption. Newer techniques like base editing and prime editing are further improving the precision and safety of gene editing for CVDs Gu2025Saeed2023Wu2024.
Synthetic Gene Circuits and Designer Cells
Synthetic gene circuits represent another innovative approach, enabling the creation of designer cells that can detect disease biomarkers and autonomously produce therapeutic agents. These circuits have shown success in experimental models for cancer remission and are being explored for infectious, metabolic, and autoimmune diseases. Their specificity and adaptability make them promising tools for both disease detection and prevention .
Ethical, Regulatory, and Policy Considerations
While the technical potential of gene editing for disease prevention is vast, ethical and policy challenges remain. There is ongoing debate about the distinction between disease prevention and human enhancement, and how to regulate research and clinical applications to maximize health benefits while minimizing risks. Policymakers are urged to develop governance frameworks that anticipate the dual-use nature of gene editing technologies and address concerns about unintended enhancement applications .
Conclusion
Custom gene editing holds significant promise for the prevention of a wide range of diseases, from cancer and cardiovascular conditions to rare genetic disorders. Advances in CRISPR-Cas systems, base editing, and synthetic gene circuits are driving this progress, though technical, ethical, and regulatory challenges must be carefully managed. As research and clinical trials continue, gene editing is poised to become a transformative tool in preventive medicine, potentially reshaping public health strategies in the coming years Rocha2020Gu2025Saeed2023+6 MORE.
Sources and full results
Most relevant research papers on this topic